The role of astrocytes in amyloid β-protein toxicity and clearance

Experimental Neurology
Dietmar Rudolf Thal

Abstract

The deposition of the amyloid β-protein (Aβ) in the brain is a pathological hallmark of Alzheimer's disease (AD). Here, Aβ deposits occur as Aβ plaques in the brain parenchyma and in the walls of cerebral and leptomeningeal blood vessels. Astrocytes are considered to be involved in the clearance of Aβ from the brain parenchyma into the perivascular space, across the blood-brain barrier, or by enzymatic degradation. As such it has been assumed that clearance of Aβ by astrocytes is beneficial. In a recent study published in Experimental Neurology Mulder et al. (2012; 233: 373-379) report changes in neprilysin and scavenger receptor class B member 1 gene expression in astrocytes exposed to fibrillar Aβ depending on the availability of amyloid-associated proteins, especially apolipoprotein E (apoE). Astrocytes from AD patients did not show this response in gene expression. Reactive astrocytes and Aβ containing astrocytes are common findings in the AD brain. A loss of excitatory amino acid transporter 2 expression in perivascular astrocytes of APOE ε4-positive AD cases and an alteration of neuronal apoE metabolism in the event of perivascular drainage of apoE-Aβ complexes has also been described. As such, reactive and compensatory c...Continue Reading

References

Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W S GriffinC Araoz
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Sep 1, 1994·Journal of Neuropathology and Experimental Neurology·S H HanD E Schmechel
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M E CalhounM Jucker
Mar 4, 2003·Nature Medicine·Tony Wyss-CorayJens Husemann
Oct 27, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ke-Jie YinJin-Moo Lee
Dec 5, 2006·Trends in Immunology·Ingo BechmannV Hugh Perry
Nov 13, 2008·Acta Neuropathologica·Roy O WellerRoxana O Carare
Jan 7, 2011·Journal of Neural Transmission·Harshvardhan RolyanDietmar Rudolf Thal
Sep 16, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Mark NobleStephen J A Davies

❮ Previous
Next ❯

Citations

Oct 13, 2012·The Journal of Biological Chemistry·Katherine L YoumansMary Jo Ladu
Jan 7, 2014·Molecular Neurodegeneration·Leon M TaiMary Jo LaDu
Mar 22, 2014·Neuroscience Bulletin·Evan DoreyWandong Zhang
Jan 28, 2016·Brain : a Journal of Neurology·Elena Rodriguez-VieitezAgneta Nordberg
Aug 19, 2015·Frontiers in Cellular Neuroscience·Lucile Ben HaimCarole Escartin
Feb 7, 2013·Pharmacology & Therapeutics·Elvira Valera, Eliezer Masliah
Jan 31, 2015·Neurochemistry International·Margherita EufemiM Eugenia Schininà
Aug 1, 2014·Ageing Research Reviews·Evangelina Avila-Muñoz, Clorinda Arias
Apr 22, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Elena Rodriguez-VieitezAgneta Nordberg
Nov 19, 2014·Journal of Molecular Neuroscience : MN·Bernardetta MarescaLuisa Cigliano
Sep 2, 2014·Frontiers in Aging Neuroscience·Wenjuan ZhaoG William Rebeck
Feb 24, 2015·PloS One·Ryan MathurUNKNOWN MRC Cognitive Function and Ageing Neuropathology Study Group
Sep 23, 2016·Fluids and Barriers of the CNS·Simon McArthurEgle Solito
Jun 14, 2016·Expert Review of Neurotherapeutics·William James Deardorff, George T Grossberg
Aug 8, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Michelle A Erickson, William A Banks
Mar 10, 2016·International Journal of Molecular Sciences·Yazan S BatarsehAmal Kaddoumi
Aug 3, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jong Kil Lee, Nam-Jung Kim
Apr 18, 2018·Journal of Alzheimer's Disease : JAD·Mengzhu LiJian-Zhi Wang
Dec 15, 2017·Open Biology·Georgia R Frost, Yue-Ming Li
Oct 4, 2019·Cellular and Molecular Life Sciences : CMLS·Celia A McKeeErik S Musiek
Dec 11, 2019·Current Alzheimer Research·Tao-Tao LuZhiyou Cai
Jun 6, 2018·Journal of Alzheimer's Disease : JAD·Paul Edison, David J Brooks
Nov 30, 2018·Molecular Neurobiology·D OurdevSatyabrata Kar
Aug 10, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Delphine BocheUNKNOWN MINC Faculty
May 4, 2017·The AAPS Journal·Mitchell P McInerneyJoseph A Nicolazzo
Dec 14, 2018·Molecular Neurodegeneration·Jiqing CaoDongming Cai
Jan 1, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Yuanxiao YangChangyu Li
Jul 18, 2020·Molecular Neurodegeneration·Tiantian GuoYingjun Zhao
Apr 14, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Rakesh Kumar Singh
Mar 1, 2019·Journal of Alzheimer's Disease : JAD·Kamar E Ameen-AliJason Berwick

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.